We use cookies for analytics (including your interaction with and navigation of and with this site), and to improve our site and services. For more information about our use of cookies, the information we collect, how it is used, and your rights, see our Privacy Statement.

COVID-19 and the Future of the Life Sciences Sector

May 2020
The COVID-19 pandemic has placed a spotlight on the Life Sciences sector and its real estate needs. How will the pandemic affect tenant demand for specialized Life Sciences space, and what does the development environment look like?

About the authors

Lisa DeNight is Research Manager in Newmark Knight Frank’s Philadelphia office.

 

Andrea Arata is Director of Research in Newmark Knight Frank’s San Francisco office.

For more information

Alexander (Sandy) Paul, Senior Managing Director of National Research, APaul@ngkf.com